First Manhattan’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.58M | Buy |
124,970
+35,505
| +40% | +$2.07M | 0.02% | 193 |
|
|
2025
Q4 | $4.83M | Buy |
89,465
+16,671
| +23% | +$802K | 0.01% | 234 |
|
|
2025
Q3 | $3.28M | Buy |
72,794
+38,708
| +114% | +$1.81M | 0.01% | 280 |
|
|
2025
Q2 | $1.58M | Buy |
34,086
+15,745
| +86% | +$773K | ﹤0.01% | 358 |
|
|
2025
Q1 | $1.12M | Sell |
18,341
-1,989
| -10% | -$116K | ﹤0.01% | 377 |
|
|
2024
Q4 | $1.15M | Buy |
20,330
+1,340
| +7% | +$74.9K | ﹤0.01% | 380 |
|
|
2024
Q3 | $983K | Sell |
18,990
-1,680
| -8% | -$78.8K | ﹤0.01% | 374 |
|
|
2024
Q2 | $858K | Buy |
20,670
+525
| +3% | +$23.5K | ﹤0.01% | 386 |
|
|
2024
Q1 | $1.09M | Sell |
20,145
-4,113
| -17% | -$210K | ﹤0.01% | 365 |
|
|
2023
Q4 | $1.24M | Sell |
24,258
-6,359
| -21% | -$334K | ﹤0.01% | 350 |
|
|
2023
Q3 | $1.78M | Sell |
30,617
-1,650
| -5% | -$101K | 0.01% | 322 |
|
|
2023
Q2 | $2.06M | Sell |
32,267
-1,375
| -4% | -$92.2K | 0.01% | 301 |
|
|
2023
Q1 | $2.33M | Sell |
33,642
-3,889
| -10% | -$274K | 0.01% | 299 |
|
|
2022
Q4 | $2.7M | Buy |
37,531
+5,198
| +16% | +$392K | 0.01% | 300 |
|
|
2022
Q3 | $2.3M | Sell |
32,333
-278
| -0.9% | -$20.2K | 0.01% | 302 |
|
|
2022
Q2 | $2.51M | Sell |
32,611
-617
| -2% | -$47K | 0.01% | 305 |
|
|
2022
Q1 | $2.43M | Sell |
33,228
-1,129
| -3% | -$75.8K | 0.01% | 340 |
|
|
2021
Q4 | $2.14M | Sell |
34,357
-18,854
| -35% | -$1.11M | 0.01% | 335 |
|
|
2021
Q3 | $3.15M | Sell |
53,211
-3,204
| -6% | -$211K | 0.01% | 268 |
|
|
2021
Q2 | $3.77M | Sell |
56,415
-5,534
| -9% | -$361K | 0.01% | 261 |
|
|
2021
Q1 | $3.91M | Sell |
61,949
-3,640
| -6% | -$226K | 0.02% | 260 |
|
|
2020
Q4 | $4.07M | Sell |
65,589
-16,714
| -20% | -$1.03M | 0.02% | 245 |
|
|
2020
Q3 | $4.96M | Sell |
82,303
-5,090
| -6% | -$306K | 0.03% | 222 |
|
|
2020
Q2 | $5.14M | Buy |
87,393
+1,893
| +2% | +$113K | 0.03% | 213 |
|
|
2020
Q1 | $4.76M | Sell |
85,500
-3,149
| -4% | -$192K | 0.03% | 209 |
|
|
2019
Q4 | $5.69M | Buy |
+88,649
| New | +$5.08M | 0.03% | 219 |
|
|
2019
Q1 | – | Sell |
-55,601
| Closed | -$2.89M | – | 1392 |
|
|
2018
Q4 | $2.89M | Buy |
55,601
+3,371
| +6% | +$181K | 0.02% | 293 |
|
|
2018
Q3 | $3.24M | Buy |
52,230
+7,440
| +17% | +$442K | 0.02% | 313 |
|
|
2018
Q2 | $2.48M | Sell |
44,790
-1,494
| -3% | -$80.7K | 0.01% | 336 |
|
|
2018
Q1 | $2.93M | Sell |
46,284
-10,033
| -18% | -$645K | 0.02% | 310 |
|
|
2017
Q4 | $3.45M | Sell |
56,317
-247,025
| -81% | -$15.5M | 0.02% | 313 |
|
|
2017
Q3 | $19.3M | Buy |
303,342
+5
| +0% | +$292 | 0.11% | 132 |
|
|
2017
Q2 | $16.9M | Sell |
303,337
-5,072
| -2% | -$276K | 0.1% | 142 |
|
|
2017
Q1 | $16.8M | Buy |
308,409
+249,216
| +421% | +$13.7M | 0.1% | 135 |
|
|
2016
Q4 | $3.46M | Buy |
59,193
+941
| +2% | +$51.4K | 0.02% | 277 |
|
|
2016
Q3 | $3.14M | Buy |
58,252
+1,113
| +2% | +$71.5K | 0.02% | 284 |
|
|
2016
Q2 | $4.2M | Buy |
57,139
+883
| +2% | +$62.4K | 0.03% | 265 |
|
|
2016
Q1 | $3.59M | Sell |
56,256
-787
| -1% | -$49.6K | 0.02% | 275 |
|
|
2015
Q4 | $3.92M | Sell |
57,043
-306
| -0.5% | -$20.2K | 0.02% | 268 |
|
|
2015
Q3 | $3.4M | Sell |
57,349
-3,343
| -6% | -$212K | 0.02% | 279 |
|
|
2015
Q2 | $4.04M | Hold |
60,692
| – | – | 0.02% | 272 |
|
|
2015
Q1 | $3.91M | Buy |
60,692
+341
| +0.6% | +$21.3K | 0.02% | 280 |
|
|
2014
Q4 | $3.56M | Buy |
60,351
+343
| +0.6% | +$19.3K | 0.02% | 294 |
|
|
2014
Q3 | $3.07M | Sell |
60,008
-336
| -0.6% | -$16.8K | 0.02% | 304 |
|
|
2014
Q2 | $2.93M | Sell |
60,344
-801
| -1% | -$39.5K | 0.02% | 308 |
|
|
2014
Q1 | $3.18M | Buy |
61,145
+859
| +1% | +$45.7K | 0.02% | 293 |
|
|
2013
Q4 | $3.2M | Buy |
60,286
+2,234
| +4% | +$114K | 0.02% | 290 |
|
|
2013
Q3 | $2.69M | Buy |
58,052
+1,700
| +3% | +$74.6K | 0.02% | 306 |
|
|
2013
Q2 | $2.46M | Buy |
+56,352
| New | +$2.45M | 0.02% | 303 |
|
Other funds holding BMY
VCM
VPM
First Manhattan's BMY Position: Q1 2026 in Review
First Manhattan increased its Bristol-Myers Squibb (BMY) stake by 40% in Q1 2026, buying an estimated $2.07M and bringing the position to 124,970 shares worth $7.58M. The position accounts for 0.02% of the portfolio, ranked #193.
First Manhattan first reported a position in BMY in Q2 2013 and has held it in 49 quarters since. The position peaked at $19.3M in Q3 2017. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- First Manhattan held 124,970 shares of Bristol-Myers Squibb worth $7.58M as of Q1 2026.
- First Manhattan bought 35,505 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.07M.
- Bristol-Myers Squibb made up 0.02% of First Manhattan's portfolio in Q1 2026, its #193 holding.
- First Manhattan first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 49 quarters since.
- First Manhattan's Bristol-Myers Squibb position peaked at $19.3M in Q3 2017.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on First Manhattan's 13F filing for Q1 2026, filed 15 May 2026.